Zilixir Biotech Company
Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating the effectiveness of protein design.
Founded Date:
2021-04-21 00:00:00
Technology:
Computational Drug Design & Virtual Screening
Headquarters:
Shanghai,Shanghai,China,Asia
Funding Status:
private
Industry:
BioPharma AI